PUBLICATION
CORRECTION: Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models
- Authors
- Li, W., Shenkar, R., Detter, M.R., Moore, T., Benavides, C., Lightle, R., Girard, R., Hobson, N., Cao, Y., Li, Y., Griffin, E., Gallione, C., Zabramski, J.M., Ginsberg, M.H., Marchuk, D.A., Awad, I.A.
- ID
- ZDB-PUB-220906-267
- Date
- 2021
- Source
- The Journal of Clinical Investigation 131(19): (Other)
- Registered Authors
- Keywords
- none
- MeSH Terms
- none
- PubMed
- 34596055 Full text @ Journal of Clin. Invest.
Citation
Li, W., Shenkar, R., Detter, M.R., Moore, T., Benavides, C., Lightle, R., Girard, R., Hobson, N., Cao, Y., Li, Y., Griffin, E., Gallione, C., Zabramski, J.M., Ginsberg, M.H., Marchuk, D.A., Awad, I.A. (2021) CORRECTION: Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models. The Journal of Clinical Investigation. 131(19).
Abstract
Following the publication of this article, the authors became aware that an incorrect panel was used for Figure 3B. The correct panel for Figure 3B is below, showing the change in heart rate when mice were challenged with isoproterenol in a murine model of cerebral cavernous malformation treated with vehicle or propranolol. The Figure 3 legend is amended as follows: ***P < 0.001, by 2-way repeated-measures ANOVA with a post hoc Tukey’s honest significant difference test. The authors have stated that this corrected panel does not affect the results or conclusions of the article.
The authors regret the error.
The authors regret the error.
Errata / Notes
This article corrects ZDB-PUB-201212-22 .
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping